Overview

Salvage Peanut Oral Immunotherapy Study

Status:
Enrolling by invitation

Trial end date:
2022-09-01

Target enrollment:

Participant gender:

Summary

The purpose of this trial is to study the safety of rescue peanut oral immunotherapy followed by the introduction of dietary peanut for patients with peanut allergy who have lost desensitization during a peanut immunotherapy trial.

Phase:

Phase 1/Phase 2

Details

Lead Sponsor:

University of North Carolina, Chapel Hill